Two Sigma Advisers
TBPH icon

Two Sigma Advisers’s Theravance Biopharma TBPH Stock Holding History

Two Sigma Advisers’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-379,500
Closed -$7.1M – 1906
2025
Q4 		$7.1M Buy
379,500
+179,200
+89% +$2.97M 0.01% 667
2025
Q3 		$2.92M Buy
200,300
+171,200
+588% +$2.16M 0.01% 958
2025
Q2 		$321K Buy
29,100
+4,400
+18% +$42.8K ﹤0.01% 1931
2025
Q1 		$221K Buy
+24,700
New +$230K ﹤0.01% 2108
2024
Q3 		– Sell
-33,900
Closed -$287K – 2521
2024
Q2 		$287K Buy
+33,900
New +$306K ﹤0.01% 2085
2023
Q3 		– Sell
-94,300
Closed -$976K – 2571
2023
Q2 		$976K Sell
94,300
-389,500
-81% -$4.3M ﹤0.01% 1542
2023
Q1 		$5.25M Sell
483,800
-524,800
-52% -$5.55M 0.01% 787
2022
Q4 		$11.3M Buy
1,008,600
+312,000
+45% +$3.28M 0.03% 480
2022
Q3 		$7.06M Buy
+696,600
New +$6.53M 0.02% 602
2022
Q2 		– Sell
-10,700
Closed -$102K – 2866
2022
Q1 		$102K Buy
+10,700
New +$105K ﹤0.01% 2503
2021
Q2 		– Sell
-29,800
Closed -$608K – 2688
2021
Q1 		$608K Sell
29,800
-7,200
-19% -$137K ﹤0.01% 1926
2020
Q4 		$657K Sell
37,000
-42,800
-54% -$768K ﹤0.01% 1757
2020
Q3 		$1.18M Buy
79,800
+28,400
+55% +$532K ﹤0.01% 1431
2020
Q2 		$1.08M Buy
+51,400
New +$1.32M ﹤0.01% 1546
2016
Q4 		– Sell
-6,200
Closed -$225K – 2451
2016
Q3 		$225K Buy
+6,200
New +$173K ﹤0.01% 1996

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Advisers's TBPH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 379,500 shares — an estimated $7.1M sold.

Two Sigma Advisers first reported a position in TBPH in Q3 2016 and held it in 15 quarters. The position peaked at $11.3M in Q4 2022. 174 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Two Sigma Advisers reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 379,500 Theravance Biopharma shares in Q1 2026, an estimated $7.1M.
  • Two Sigma Advisers first reported a position in Theravance Biopharma in Q3 2016 and held it in 15 quarters.
  • Two Sigma Advisers's Theravance Biopharma position peaked at $11.3M in Q4 2022.
  • 174 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.